October 5, 2015
Evgen Pharma to join the AIM market of the London Stock Exchange
Evgen Pharma plc, a clinical stage drug development company focused on the treatment of cancer and neurological conditions, intends to join the AIM market of the London Stock Exchange by way of a Placing to raise approximately £5 million.